ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy, Tolerability, and Safety of NXN-462 in Patients With Post-Herpetic Neuralgia

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01748877
Recruitment Status : Completed
First Posted : December 13, 2012
Last Update Posted : June 19, 2014
Sponsor:
Information provided by (Responsible Party):
NeurAxon Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : June 2014
  Actual Study Completion Date : June 2014